Invezz
搜索文档
Cracker Barrel shares slide after retailer cuts revenue outlook
Invezz· 2025-12-10 20:38
公司业绩与股价表现 - 公司股价在周三大幅下跌 [1] - 公司下调了年度营收预期 [1] - 公司公布的季度业绩弱于预期 [1] 公司经营状况 - 公司是一家位于田纳西州的餐饮与零售连锁店 [1] - 公司业绩受到不利因素拖累 [1]
How the Fed's rate cut decisions could shape the market's next move
Invezz· 2025-12-10 20:33
The Federal Reserve's final policy meeting of the year arrives at a moment when the stock market is once again within striking distance of record highs. ...
What to expect from Oracle's Q2 results?
Invezz· 2025-12-10 19:18
Oracle Corp. heads into its fiscal second-quarter earnings report facing mounting scrutiny from investors, who have grown increasingly uneasy about the software giant's rising leverage, heavy capital ... ...
Rolls-Royce share price eyes a rebound as a bullish pattern forms
Invezz· 2025-12-10 18:23
公司股价表现与市场地位 - 罗尔斯·罗伊斯股价近期保持稳定,从11月24日的低点1,020便士升至当前1,110便士[1] - 公司股价较1月低点已上涨超过100%,略低于年内高点1,195便士[1] - 股价已从2022年低点62.15便士飙升至当前1,112便士,涨幅达1,527%,推动其市值超过1,260亿美元,成为英国最大的公司之一[2] 财务业绩与经营状况 - 公司已从首席执行官曾描述的“燃烧的平台”转变为高盈利企业[3] - 管理层在近期交易声明中重申了盈利和现金流的前瞻指引[3] - 公司预计全年营业利润在31亿至32亿英镑之间,自由现金流在30亿至31亿英镑之间[3] 业务增长驱动因素 - 民用航空业务增长得益于从IndiGo和马来西亚航空等公司获得的大额订单,且活跃飞行小时数已超过疫情前水平[4] - 国防业务受益于行业繁荣,例如德国议会即将投票表决一项500亿欧元的支出计划,该计划将主要惠及欧洲国防承包商[4] - 小型模块化反应堆业务已获得英国政府的大额订单,并正与其他国家进行谈判[5] - 公司计划将SMR业务扩展至美国,特朗普政府近期宣布了一项8亿美元的投资计划,该计划将使田纳西州和密歇根州等地受益[5] 行业竞争与估值 - 公司自20世纪50年代起涉足核能行业,是该领域的顶级参与者,可能最终成为Oklo和NuScale等市值数十亿美元公司的强大竞争对手[6] - 尽管股价表现强劲,公司估值并不昂贵,其追踪市盈率为16.9倍,远低于标普500指数22倍的平均水平[6] 股价技术分析 - 日线图显示股价在过去几天保持看涨基调,从11月低点1,020便士升至当前1,112便士[9] - 股价已站上50日和100日指数移动平均线,表明多头目前仍掌控局面[9] - 股价已形成扩音器形态和看涨旗形,后者是技术分析中常见的持续看涨信号[10] - 最可能的情况是股价继续上涨,下一个关键目标位是年内高点1,195便士[11]
Nintendo shares fall as global memory squeeze raises risks for Switch 2
Invezz· 2025-12-10 15:03
公司股价表现 - 任天堂股价在周三下跌多达2.6% [1] 行业供应链动态 - 科技供应链正发生更广泛的转变,内存成本上升的影响正蔓延至游戏硬件领域 [1]
JPMorgan stock dives after 2026 cost warning: is this the red flag investors feared?
Invezz· 2025-12-10 05:05
JPMorgan stock (NYSE: JPM) tanked nearly 5% on Tuesday after the bank's consumer banking chief warned that 2026 expenses will reach $105 billion. Wall Street wasn't pricing in this magnitude of expens... ...
Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?
Invezz· 2025-12-10 04:30
Pfizer is rolling the dice again on an oral obesity pill. The pharmaceutical giant signed an exclusive global license agreement with YaoPharma, a subsidiary of China's Fosun Pharma. ...
Jim Cramer says CVS stock may be the only first-class healthcare name we have
Invezz· 2025-12-10 02:41
Famed investor Jim Cramer says he "salutes†DaviCVSd Joyner after CVS Health (NYSE: CVS) raised its profit guidance for 2026 – reinforcing the new management's turnaround plan is starting to bear frui... ...
Twenty One Capital slides 25% in NYSE debut
Invezz· 2025-12-10 01:39
Twenty One Capital began trading on the New York Stock Exchange under the ticker XXI and fell 25% early in its first day, trading at about $10.50. The New York listing follows the completion of the co... ...
Gold's short-term shine: geopolitical risk and EU reserve plans drive favourable outlook
Invezz· 2025-12-10 01:22
Gold will remain favourable in the short term due to the uncertainties in the geopolitical environment around the world. The ongoing EU plans regarding frozen Russian reserves serve as a further comp... ...